Biotechnology - Licensing, Valneva

Filter

Current filters:

LicensingValneva

Popular Filters

Valneva initiates fourth antibody discovery program for Sanofi Pasteur

25-02-2014

European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Valneva licenses EB66 to IAVI for preventive HIV vaccine

02-10-2013

Biotech firm Valneva says that it has licensed the use of its EB66 cell line to the International AIDS…

Anti-viralsBiotechnologyLicensingVaccinesValneva

Valneva enters deals with Delta-Vir

13-09-2013

Biotech firm Valneva (Euronext: VLA), the company recently created through the merger of France's Vivalis…

Anti-viralsBiotechnologyDelta-VirLicensingOncologyValneva

Back to top